Home/Filings/4/0000950170-25-023428
4//SEC Filing

Shaw Christi 4

Accession 0000950170-25-023428

CIK 0001994702other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 5:55 PM ET

Size

5.3 KB

Accession

0000950170-25-023428

Insider Transaction Report

Form 4
Period: 2025-02-14
Shaw Christi
DirectorExecutive Chairperson
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-14+38,67938,679 total
    Exercise: $3.03Exp: 2035-02-14Common Stock (38,679 underlying)
Footnotes (1)
  • [F1]100% of the shares subject to the option shall be fully vested and exercisable on October 30, 2025, subject to the Reporting Person's continuous service to the Issuer as an advisor on and through the vesting date, inclusive.

Documents

1 file

Issuer

Kyverna Therapeutics, Inc.

CIK 0001994702

Entity typeother

Related Parties

1
  • filerCIK 0001702473

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:55 PM ET
Size
5.3 KB